• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Philips Respironics

Philips updates use instructions for several ventilators following recalls

November 20, 2024 By Sean Whooley

The FDA issued a notice updating instructions for a number of ventilators made by Philips (NYSE:PHG) Respironics. This recall involves updating instructions for devices, not removing them from use or sale. The FDA identified the recall as the most serious kind, as it may cause serious injury or death. It relates to an October warning […]

Filed Under: Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Respiratory Tagged With: FDA, Philips, Philips Respironics

Philips to pay $25M to monitor people affected by CPAPs recall

November 18, 2024 By Chris Newmarker

A federal judge recently approved Philips paying $25 million to monitor and research the affects of its major respiratory devices recall. The monitoring will occur over the next 15 years, according to the settlement approved Oct. 31 by U.S. District Judge Joy Flowers Conti in western Pennsylvania. Conti is overseeing all federal lawsuits involving the […]

Filed Under: Featured, Legal News, Product Liability, Respiratory Tagged With: Philips, Philips Respironics

Philips warns on Trilogy ventilator nebulizers following recall

October 8, 2024 By Sean Whooley

Philips Respironics has issued additional usage instructions as part of a voluntary recall of some of its ventilators. Last week, the FDA designated a recall of Trilogy Evo, Trilogy EV300, Trilogy Evo O2, Trilogy Evo Universal ventilators as Class I, the most serious kind. The issue centered around software errors, including an inaccurate display of […]

Filed Under: Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Respiratory Tagged With: Philips, Philips Respironics, Royal Philips

Philips has another Class I level ventilator recall

October 2, 2024 By Chris Newmarker

Philips continues to have serious respiratory device recalls, more than three years into a major safety crisis for its Respironics business.  Yesterday, the FDA designated a recall of Trilogy Evo, Trilogy EV300, Trilogy Evo O2, Trilogy Evo Universal ventilators as Class I, it’s most serious level. Philips says the action involves roughly 90,000 units worldwide, […]

Filed Under: Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Respiratory Tagged With: Philips, Philips Respironics

FDA corrects death tally in Philips ventilator recall

July 12, 2024 By Sean Whooley

The FDA issued a clarification that significantly trims the number of deaths reportedly associated with a recall of Philips Respironics ventilators. On June 28, the FDA issued a Class I recall notice involving potential Ventilator Inoperative alarm failures on BiPAP V30, BiPAP A30, BiPAP A40 devices. At the time, the FDA cited 952 reports of […]

Filed Under: Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Respiratory Tagged With: FDA, Philips, Philips Respironics, Royal Philips

Philips is downsizing Respironics operations in Pennsylvania

June 20, 2024 By Chris Newmarker

Royal Philips (NYSE: PHG) announced this week that it is shuttering its Respironics business’ Pittsburgh headquarters and slashing hundreds of manufacturing jobs in the region. In a statement shared with local media, the Dutch medtech giant said it will exit its headquarters building in Bakery Square in Pittsburgh, moving 500 jobs to nearby facilities in […]

Filed Under: Business/Financial News, Featured, Respiratory Tagged With: Layoffs, Philips, Philips Respironics

How Philips’ significant respiratory devices recall unfolded

June 20, 2024 By Chris Newmarker

There are 5.5 million recalled CPAPs and other devices — and reports of deaths. Here’s a Philips recall timeline. Philips in mid-2021 kicked off a recall that involved millions of CPAP and BiPAP ventilators and other respiratory devices. The devices — used for sleep apnea therapy and more — had sound abatement foam that could […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), In-Depth Coverage, News Well, Regulatory/Compliance, Respiratory, Special Content Tagged With: CPAP, Philips, Philips Respironics

Philips warns on more BiPAP ventilators in Europe, reports 7 deaths related to issue

May 28, 2024 By Sean Whooley

Philips issued an urgent field safety notice in Europe to warn of issues with some of its bi-level positive airway pressure (BiPAP) ventilators. The company’s notice said it received 888 complaints regarding interruptions and/or loss of therapy with several BiPAP devices. The list includes the BiPAP A30, A30 EFL, A30 Hybrid, A40, A40 EFL and […]

Filed Under: Featured, Recalls, Regulatory/Compliance, Respiratory Tagged With: Philips, Philips Respironics, Royal Philips

Philips stock skyrockets on positive outlook, $1.1B Respironics settlement in spite of Q1 misses

April 29, 2024 By Sean Whooley

Philips shares got a huge boost today despite first-quarter results that fell shy of the consensus forecast on Wall Street. Investors appeared to react positively to recent updates on the company’s long-running Respironics recall. Shares of PHG rose more than 35% to $28.50 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Philips, Philips Respironics, Royal Philips

Philips gets judge’s OK to settle Respironics recall economic losses

April 26, 2024 By Chris Newmarker

Philips will pay at least $613 million to settle economic lawsuits related to its recall of millions of CPAPs and other respiratory devices. U.S. District Court Judge Joy Flowers Conti, who has been overseeing the multidistrict litigation out of her court in Western Pennsylvania, approved the final settlement yesterday. “The amount of value created and […]

Filed Under: Featured, Food & Drug Administration (FDA), Legal News, Product Liability, Recalls, Regulatory/Compliance, Respiratory Tagged With: Philips, Philips Respironics, Royal Philips

Philips comes to consent decree agreement with DOJ, FDA over Respironics recall

April 10, 2024 By Sean Whooley

Philips today announced a final agreement on a consent decree with the FDA and U.S. Dept. of Justice (DOJ). The consent decree primarily focuses on its Philips’ Pennsylvania-based Respironics business — the subject of a major recall over the past several years. That includes manufacturing facilities in Murrysville and New Kensington, a service center in […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Legal News, Recalls, Regulatory/Compliance, Respiratory Tagged With: Philips, Philips Respironics, Royal Philips

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy